Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Participants with higher forced vital capacity, indicating better lung function, were less likely to develop heart disease, diabetes, and stroke over 10 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback